> HDMA Testifies
      Supporting HR5839

> HDMA Applauds
      Introduction of
      HR 5839

> HDMA Applauds
      NCPA, FBI LEEDA and
      Purdue Pharma

> HDMA Commends
      California Board of
      Pharmacy Decision

> New Data Management
      & Sharing Research
      Now Available!


print page

 

 

 

HDMA New Rx Product Introduction Form

This form has been expanded from the original one-page to the current two-page form that not only allows inclusion of more information about a product being introduced to the market, but also allows for greater detail on information formerly identified. It fills an industry requirement for pharmaceutical drug manufacturers to provide additional, more specific, information to distributors of their product including any special handling, storage, and temperature requirements as well as detailed packing description. The new form also provides detail on a drug product’s status as a hazardous material or precursor chemical, and related special transportation requirements.
 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D